5-hydroxydecanoate has been researched along with MPTP Neurotoxicity Syndrome in 1 studies
5-hydroxydecanoic acid: Potassium Channel Blocker; RN refers to parent cpd
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Yang, YJ | 1 |
| Zhang, S | 1 |
| Ding, JH | 1 |
| Zhou, F | 1 |
| Hu, G | 1 |
1 other study available for 5-hydroxydecanoate and MPTP Neurotoxicity Syndrome
| Article | Year |
|---|---|
Iptakalim protects against MPP+-induced degeneration of dopaminergic neurons in association with astrocyte activation.
Topics: 1-Methyl-4-phenylpyridinium; Analysis of Variance; Animals; Animals, Newborn; Astrocytes; Brain Stem | 2009 |